AstraZeneca’s India Layoffs Vastly Reduce R&D Work In Country
This article was originally published in PharmAsia News
Executive Summary
When AstraZeneca laid off 15 scientists as part of a 19-employee staff cut in India, it may have struck a blow against drug-discovery work in the country.